CB Financial Services extended its common-stock repurchase program to August 31, 2027, from September 30, 2026, while retaining authority to buy up to $5.0 million of shares. The longer authorization period keeps the previously announced buyback available beyond its original end date.
Key Highlights
- The repurchase program’s termination date now runs through August 31, 2027.
- The authorization covers purchases of up to $5.0 million of outstanding common stock.
- The previous end date was September 30, 2026.
CB Financial Services, Inc. (NASDAQ: CBFV) extended the end date of its common-stock repurchase program to August 31, 2027. The program covers repurchases of up to $5.0 million of outstanding common stock.
$5.0M Repurchase Program Extended
The program had been due to end on September 30, 2026. CB Financial Services moved that date to August 31, 2027, for the previously announced program to repurchase up to $5.0 million of outstanding common stock. The update was dated September 16, 2026. Amanda L. Engles signed on behalf of CB Financial Services as Executive Vice President and Chief Financial Officer.
FAQs
Q: What is the new deadline for the CB Financial Services stock buyback?
A: CB Financial Services extended the termination date of its common-stock repurchase program to August 31, 2027. The filing identifies that date as the program’s new termination date.
Q: How much common stock can CB Financial Services repurchase?
A: CB Financial Services can repurchase up to $5.0 million of outstanding common stock under the program. The filing identifies the authorization by dollar value rather than by a specified share count.
Q: When was the CB Financial Services repurchase program previously set to end?
A: The program was previously scheduled to terminate on September 30, 2026. CB Financial Services replaced that date with August 31, 2027, according to the filing.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.